$16.94 B
Share price
Change (1 day)
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

Revenue for Celltrion (068270.KS)

Revenue in 2022 (TTM): $1.88 B

According to Celltrion 's latest financial reports the company's current revenue (TTM) is $1.88 B. In 2021 the company made a revenue of $1.64 B an increase over the years 2020 revenue that were of $1.59 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Celltrion from 2008 to 2022

Annual revenue

Year Revenue Change
2022 (TTM)$1.88 B14.65%
2021$1.64 B3.4%
2020$1.59 B64.11%
2019$0.96 B8.61%
2018$0.89 B4.96%
2017$0.85 B46.26%
2016$0.58 B11.08%
2015$0.52 B16.53%
2014$0.44 B117.1%
2013$0.20 B-35.55%
2012$0.32 B
2010$0.15 B34.6%
2009$0.11 B61.86%
2008$71.98 M